GENE ONLINE|News &
Opinion
Blog

Feature
COVID-19 Clinical Trial
GSK, Vir Collaboration Drives Advanced Clinical Trial for Novel COVID-19 Antibody Forward
2020-10-11
Technology 3D Printing
A.D.A.M’s Regulatory Progress Takes 3D Printed Bones a Step Closer to Reality
2020-10-11
In-Depth
Tumor Drug Resistance Helps Identify a Novel Therapy for Leukemia
2020-10-11
COVID-19 COVID-19 Antibody
COVID-19: Eli Lilly Claims Efficacy, Seeks Speedy Emergency Use Authorization for Antibody Therapy
2020-10-09
Technology Cas9
CRISPR Pioneers Bag 2020 Nobel Prize in Chemistry
2020-10-07
COVID-19 Interferon
Interferons May Hold the Key to the Severity of COVID-19
2020-10-03
COVID-19 Antibody
COVID-19: Early Data Shows Regeneron’s Antibody Cocktail Curbs Virus, Speeds Recovery
2020-10-01
COVID-19 Vaccine
COVID-19: J&J’s Vaccine Candidate Registers Strong Immune Response in Early Trials
2020-09-29
COVID-19 Vaccine
FDA Halts Another Coronavirus Vaccine Trial
2020-09-29
COVID-19 qPCR
Pioneering Nanopore Sequencing-Based COVID Diagnostic Bags Emergency Use Approval
2020-09-27
Technology miRNA Therapy
Combining the Power of miRNAs and Nanotechnology to Prevent Osteoarthritis Progression
2020-09-27
Feature Cannabidiol
Spotlight: Cannabidiol (CBD) Based Medication Heralds New Promise in Neurological Therapies
2020-09-22
COVID-19 Vaccine
Moderna Gives Updates on Its Diversified Pipeline at R&D Day
2020-09-19
Technology Gene Editing
Exploring RNA Splicing as a Potential New Drug Avenue for Parkinson’s Disease
2020-09-16
COVID-19 Vaccine
Recent Updates on COVID-19 Vaccines Development
2020-09-15
1 … 46 47 48 49 50 … 60
LATEST
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Mastering Gene & Cell Therapy: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top